XML 35 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Basis of Presentation and Significant Accounting Policies (Details Textual) (USD $)
Share data in Millions, except Per Share data, unless otherwise specified
1 Months Ended 3 Months Ended 7 Months Ended 9 Months Ended 12 Months Ended 3 Months Ended 1 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 1 Months Ended 6 Months Ended 3 Months Ended 9 Months Ended
Jun. 29, 2012
Y
Apr. 19, 2011
Apr. 19, 2011
Jul. 01, 2011
Jun. 29, 2012
Y
Apr. 30, 2011
Jun. 29, 2012
Y
Jul. 01, 2011
Sep. 30, 2011
Mar. 30, 2012
Customer relationships [Member]
Jun. 29, 2012
Patents [Member]
Jun. 29, 2012
R & D assets [Member]
Mar. 30, 2012
In-process research and development [Member]
Jun. 29, 2012
In-process research and development [Member]
Mar. 30, 2012
Trade name and trademarks [Member]
Apr. 19, 2011
Predecessor
Apr. 19, 2011
Predecessor
Oct. 01, 2010
Predecessor
Jul. 01, 2011
Successor [Member]
Jun. 29, 2012
Successor [Member]
Sep. 30, 2011
Successor [Member]
Apr. 19, 2011
Successor [Member]
Jun. 29, 2012
Maximum [Member]
Jun. 29, 2012
Minimum [Member]
Basis of Presentation and Significant Accounting Policies (Textual) [Abstract]                                                
Equity method of accounting if the investment gives the Company the ability to exercise significant influence over                                             50.00% 20.00%
Income taxes paid                                 $ 400,000   $ 200,000 $ 500,000        
Interest paid                                  10,200,000     9,800,000        
Asset impairments 0 0   0    0       15,400,000 0 0 6,000,000 900,000 1,100,000         22,000 54,869,000        
Fair value of in-process research and development                         1,900,000 1,900,000                    
Historial carrying value of in-process research and development.                         2,800,000 2,800,000                    
Impairment of indefinite intangible asset             23,400,000   41,100,000       900,000 900,000                    
Payments for merger related costs     100,000                           6,400,000   9,200,000          
Cash and cash equivalents                               60,794,000 60,794,000 54,466,000 50,408,000 23,309,000 38,056,000 60,794,000    
Common stock, par value per share                                       $ 0.01 $ 0.01      
Basis of Presentation and Significant Accounting Policies (Additional Textual) [Abstract]                                                
Interest rate of convertible subordinated notes             4.00%                                  
Cash consumption             (14,700,000)                   (5,429,000)   197,422,000          
Long term debt, including semi-annual interest payments             9,800,000                                  
Date of completion of Merger with Gold Acquisition Corp.             Apr. 19, 2011                                  
Last date for trading company shares             Apr. 19, 2011                                  
Amount of cash per share that shareholder has right to receive   $ 2.40 $ 2.40                                          
Aggregate consideration of all equity securities in merger   203,800,000 203,800,000                                          
Amount of equity contributions to fund merger     203,900,000                                          
Investment in Uptown Newport L.P.             7.50%                                  
Inventory rotation ratio 10.00%       10.00%   10.00%                                  
Inventory rotation times, per year 2       2   2                                  
Accrued rebates at time of sale 100.00%       100.00%   100.00%                                  
Cash held that is insured by Federal Deposit Insurance Corporation 400,000       400,000   400,000                                  
Restricted Investments 4,700,000       4,700,000   4,700,000   5,100,000                              
Investment value at equity method 400,000       400,000   400,000                                  
Company redeemed remaining convertible notes, amount               11,200,000                                
Company warrant to purchase shares 6.1       6.1   6.1                                  
Redemption date of notes               Mar. 01, 2011                                
Goodwill impairment charge             $ 31,500,000